Generic Name |
Brand Name |
Breast cancer type |
Breast cancer stage |
Where in the drug approval process is this treatment |
Capecitabine |
Xeloda; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Carboplatin |
various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Cisplatin |
various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Cyclophosphamide |
Procytox; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Docetaxel |
Taxotere; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Doxorubicin |
Adriamycin; Myocet; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Epirubicin |
Pharmorubicin; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Eribulin |
Halaven |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Fluorouracil |
Actikerall; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Gemcitabine |
Gemzar; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Lapatinib |
Tykerb |
HER2+ |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Methotrexate |
Metoject; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Mitoxantrone |
various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Neratinib |
Nerlynx |
HR+, HER2+ |
Stage 0, I, II, III |
Health Canada - Approved |
Paclitaxel |
Taxol; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Paclitaxel-nab |
Abraxane |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Pegylated Liposomal Doxorubicin |
Caelyx |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Health Canada - Approved |
Pertuzumab |
Perjeta |
HER2+ |
Stage Ib, II, III |
Listed on Provincial Drug Formulary |
Pertuzumab |
Perjeta |
HER2+ |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Pertuzumab, Trastuzumab & hyaluronidase-zzxf subcutaneous |
PHESGO (Perjeta, Herceptin & hyaluronidase-zzxf subcutaneous) |
HER2+ |
Stage Ib, II, III |
Health Canada - Approved |
Pertuzumab, Trastuzumab & hyaluronidase-zzxf subcutaneous |
PHESGO (Perjeta, Herceptin & hyaluronidase-zzxf subcutaneous) |
HER2+ |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Temozolomide |
Temodal; various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Trastuzumab |
Herceptin |
HER2+ |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Trastuzumab biosimilar |
Herzuma (biosimilar) |
HER2+ |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Trastuzumab biosimilar |
Ontruzant (biosimilar) |
HER2+ |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Trastuzumab biosimilar |
Kanjinti (biosimilar) |
HER2+ |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Trastuzumab biosimilar |
Ogivri (biosimilar) |
HER2+ |
Stage 0, I, II, III |
Listed on Provincial Drug Formulary |
Trastuzumab biosimilar |
Trazimera (biosimilar) |
HER2+ |
Stage 0, I, II, III, Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Trastuzumab biosimilar |
Herzuma (biosimilar) |
HER2+ |
Stage 0, I, II, III |
Listed on Provincial Drug Formulary |
Trastuzumab deruxtecan |
Enhertu |
HER2+ |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Trastuzumab emtansine |
Kadcyla |
HER2+ |
Stage Ib, II, III |
Listed on Provincial Drug Formulary |
Trastuzumab emtansine |
Kadcyla |
HER2+ |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Trastuzumab Subcutaneous |
Herceptin SC |
HER2+ |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved |
Trastuzumsab biosimilar (with pertuzumab and a taxane) |
Ogivri |
HER2+ |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Tucatinib |
Tukysa |
HER2+ |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |
Vinorelbine |
various brand names |
HR+, HER2-, HER2+, Triple Negative |
Stage IV (metastatic) |
Listed on Provincial Drug Formulary |